Suicide Risk Higher for Cancer Patients Not Proceeding With Recommended Surgery
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- Higher suicide deaths are seen among cancer patients who do not undergo recommended surgery, according to a research letter published online Sept. 3 in JAMA Network Open.
Michael L. Chen, from Stanford University in California, and colleagues used the Surveillance, Epidemiology, and End Results Program 17 Registries database (2000 to 2020) to investigate whether specific cancer treatment modalities are associated with suicide deaths. The analysis included 5.16 million patients with a first primary cancer diagnosis.
The researchers found that 0.1 percent of patients died by suicide. Among patients not undergoing surgery, suicide deaths were highest for pancreatic, esophageal, lung or bronchial, and stomach cancers. Standardized mortality ratios varied by surgical status, but increased suicide deaths were seen among patients who did not undergo surgery. Across all cancer stages, patients who did not undergo surgery but who were recommended surgery with high reliability had the highest suicide deaths. Patients with pancreatic cancer had a 331 percent higher suicide incidence than the general population, but this rate varied by treatment modality: 77 percent higher with surgery, 598 percent higher without surgery, and 1,011 percent higher without surgery even though surgery was recommended. Similar patterns were seen by cancer stage, race and ethnicity, age, and sex by surgical status. There were no associations noted between undergoing radiotherapy or chemotherapy and suicide deaths.
"Even among patients with advanced cancer stage, suicide deaths were lower among those who underwent surgery, suggesting that advanced stage alone does not account for differences by treatment," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Capsule Sponge + Biomarkers Can Stratify Risk in Barrett Esophagus
MONDAY, June 30, 2025 -- In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying those at highest risk...
Late-Life Mood Disorders May Indicate Predisposition to Dementia
MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...
Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer
FRIDAY, June 27, 2025 -- For patients with locally advanced head and neck squamous cell carcinoma (HNSCC), the addition of neoadjuvant and adjuvant pembrolizumab to standard care...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.